Get the Stockscreener App
1.90
1.55%
-0.03
Therapeuticsmd Inc stock is traded at $1.90, with a volume of 32,795.
It is down -1.55% in the last 24 hours and down -12.84% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
See More
Previous Close:
$1.93
Open:
$1.93
24h Volume:
32,795
Relative Volume:
1.68
Market Cap:
$21.99M
Revenue:
$3.35M
Net Income/Loss:
$86,000
P/E Ratio:
123.38
EPS:
0.0154
Net Cash Flow:
$2.67M
1W Performance:
-7.77%
1M Performance:
-12.84%
6M Performance:
-8.65%
1Y Performance:
+81.82%
1-Day Range:
$1.88
$1.95
1-Week Range:
$1.88
$2.05
52-Week Range:
$1.0321
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.90 | 21.99M | 3.35M | 86,000 | 2.67M | 0.0154 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc (NASDAQ: TXMD) Share Price, TXMD Stock News, TXMD Share Price & Updates - Kalkine
TherapeuticsMD (TXMD) Edges Higher to $1.97 as Shares Hold Above Key SupportThematic ETF Flow - https://www.dars.gov.et/
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc (NASDAQ: TXMD) Share Price, TXMD Stock News, TXMD Share Price & Updates - kalkine.ca
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TXMD Q3 2023 Earnings: EPS Misses by 154.9% as Revenue Remains at ZeroEBITDA Margin Trends - vinanet.vn
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeLong Setup Ideas - vinanet.vn
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCombination Correction - dars.gov.et
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCup and Handle - careplusvn.com
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
THERAPEUTICSMD STOCK : BIG PRICE RECOVERY | TXMD STOCK Moon (nkL8YZ0GKj) - Mshale
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingAnalyst Drop Coverage - vinanet.vn
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingPre-Announcement Alert - siam.in
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingGross Profit Margin - dars.gov.et
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordHigh Volume Node - vinanet.vn
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordKey Reversal Day - vinanet.vn
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordSocial Sentiment - careplusvn.com
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordADD Alert - dars.gov.et
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordPut Call Ratio - www.dars.gov.et
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionLiquidity Order Flow - vinanet.vn
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionDealer Gamma - siam.in
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionVolume Spike Alerts - careplusvn.com
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionWave Truncation - dars.gov.et
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseSegment Revenue Breakdown - vinanet.vn
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD, Inc. Revenue Breakdown – NASDAQ:TXMD - TradingView
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseInterim Report - careplusvn.com
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseReturn On Equity - dars.gov.et
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
8.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):